Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.
Journal: Cancers
Published: January 08, 2026
Outcomes of Patients With Solid Tumor Treated on Phase I Clinical Trials Within a Comprehensive Cancer Center's Private and Safety-Net Hospitals.
Journal: JCO oncology practice
Published: December 03, 2025
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.
Journal: Liver cancer
Published: October 07, 2025
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.
Journal: Cancer
Published: September 10, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.
Journal: EBioMedicine
Published: July 03, 2025
Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond.
Journal: Therapeutic advances in medical oncology
Published: June 04, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer.
Journal: Annals of surgery
Published: March 24, 2025
Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRASG12D-mutated pancreatic cancer.
Journal: Experimental hematology & oncology
Published: January 15, 2025
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.
Journal: JCO precision oncology
Published: December 06, 2024
Last Updated: 09/26/2026